We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

IMPAACT P1085: Human Papilloma Virus (HPV) Type-Specific Antibody (HPV)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01206556
First Posted: September 22, 2010
Last Update Posted: April 1, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)